Current Issue: Volume 29 (Supplement A) 2007

CONTENTS

• Keynote lecture:
  • The impact of monoclonal antibodies on diagnosis and therapy
• Plenary lecture 1:
  • Biology and diagnostic applications of plasma nucleic acids
• Plenary lecture 2:
  • Systematic approach to diagnosing prostate cancer
• Plenary lecture 3:
  • Cybernetics of cytokines and chemokines: pathophysiology and clinical        applications
• Plenary lecture 4:
  • The history of CAMPATH-1 antibody
• Special lecture:
  • Meeting the challenges of globalisation and miniaturization
• Presidential Symposium:
  • New models for laboratory testing in a global environment
  • Pathology workforce crisis and training
  • Laboratory ethics
• Symposium 1A: Current updates on laboratory management
  • Reconstruction of the clinical laboratory – extended service to clinical        medicine
  • Total laboratory automation – pros and cons
  • The role of the clinical pathologist in supporting clinical decisions
• Symposium 1B: New developments in myeloma management
  • Pathogenesis of myeloma – insights from dtZ trial
  • New and relevant investigations for diagnosis and monitoring in        myeloma
  • Are newer agents for myeloma treatment curative?
• Symposium 1C: New paradigms in anti-infective therapy
  • RNA Interference – The role of siRNAs as alternative therapeutic        agents
  • Nanotechnology in early disease detection and diagnostics
  • Turning the tables on quorum sensing – autoinducers of quorum        sensing as targets for infection control
• Symposium 1D: Diagnostic challenges in urogenital pathology
  • Mimickers of high grade prostatic intraepithelial neoplasia (HGPIN)
  • Testicular tumours
• Symposium 1E: Managing mass disasters
  • Identification and repatriation
  • Mass grave investigations
  • Global cooperation in mass disasters
• Symposium 2A: Technological advances
  • Lean Six Sigma in laboratory service
  • Lab optimization via automation
  • Tumor chemosensitivity and chemoresistance assays
• Symposium 2B: Recent advances in blood cancers
  • The diagnosis and treatment of natural killer cell malignancies
  • The bone marrow differential count: uncertainties and unknowns
  • How curable is the low grade indolent lymphoma?
• Symposium 2C: Metagenomics
  • Metagenomics: discovering microbial diversity
  • Metagenomics: mining novel genes
  • Lab-on-Chips
• Symposium 2D: Problem areas in surgical pathology
  • Diagnostic issues in gastrointestinal pathology
  • Classification of and approach to interstitial lung disease
  • Placental Pathology
• Symposium 2E: Forensic autopsy
  • MRI/CT assisted autopsy
  • The modern approach to the negative autopsy
  • Death in healthcare and forensic pathology
• Symposium 3A: Inflammatory markers
  • Inflammatory markers and cardiovascular diseases – bystanders or        culprits?
  • Clara cell 10 kDa protein as an anti-inflammatory marker
  • Inflammatory markers and cancers
• Symposium 3B: Risk management in myeloproliferative disorders
  • How useful is the WHO Classification of the myelodysplastic syndromes
  • Thrombosis risk in the chronic myeloproliferative disorders
  • Overcoming blast crisis in chronic myeloid leukaemia – have we been        successful?
• Symposium 3C: Importance of information technology in infectious        diseases
  • Microarray gene expression analysis
  • Bioinformatics analysis in the diagnosis and management of human        genetic diseases - challenges and opportunities
• Symposium 3D: Surgical pathology of the liver
  • Clinico-morphological patterns of hepatitis
  • Paediatric liver diseases: histopathologic patterns on liver biopsies
  • Reporting liver biopsies: an algorithmic approach
• Symposium 3E: Clinical forensics
  • The role of molecular methods in crime scene investigation
  • Investigation of rape
  • Criminal abortion?
• Symposium 4A: Diabetes Mellitus
  • Studies on medicinal plants useful in diabetes mellitus and diseases        associated with elevated lipids
  • Global standardisation of HbA_1c: What can we expect?
  • Autoimmunity in Diabetes mellitus
• Symposium 4B: New treatment strategies
  • Monoclonal antibodies to harness tolerance processes in        transplantation and autoimmunity
  • Arsenic trioxide in cancer therapy
  • Potential of mesenchymal stem cells in cell-based therapy
• Symposium 4C: Emerging viral diseases
  • The story of Nipah virus
  • Avian Influenza
  • Laboratory medicine of SARS
• Symposium 4D: Advances in breast cancer
  • Pathological assessment for targeted therapy
  • In situ breast carcinoma
  • Telomerase in breast cancer
• Symposium 4E: Quality Assurance Symposium
  • Developments in Quality Assurance – meeting new challenges
  • Quality assurance in microbiology
  • Virtual microscopy – Its use in diagnostic proficiency testing in        Anatomical Pathology and its potential in other disciplines
• Symposium 5A: Metabolic syndrome
  • Metabolic syndrome: its significance and application in clinical practice
  • Modification of HDL – Implication in cardiovascular disease
  • Body fat distribution – its link with diabetes and metabolic syndrome
• Symposium 5B: Molecular genetics
  • Between genotype and phenotype: genetic modifiers in beta        Thalassemia
  • Polymorphisms in hepatic lipase – a new biomarker?
  • Genetic polymorphism of warfarin resistance
• Symposium 5C: Symposium on Tuberculosis
  • MDR tuberculosis in Indonesia: Importance for standardization before        XDR widespread
  • Molecular epidemiology of Mycobacterium tuberculosis in Indonesia: A        predominance of Beijing genotype strains and its clinical significance
  • Rapid tuberculosis diagnostic test developed in the Department of        Clinical Pathology, Dr Soeotmo Hospital, Surabaya
• Symposium 5D: Cervical cytology
  • Quality issues in cervical cancer screening
  • Glandular lesions of the cervix
  • Atypical squamous cells in cervical smears – issues and controversies
• Symposium 5E: Transplant pathology
  • Liver transplant pathology: causes of late allograft dysfunction
  • Liver transplantation and new therapeutic approaches for familial        amyloidotic polyneuropathy (FAP)
  • Neuropathology of bone marrow transplantation
• Symposium 6A: Therapeutic drug monitoring
  • Quality control of therapeutic drug monitoring
  • Therapeutic drug monitoring of antiretroviral drugs
  • Immunosuppressive drug monitoring
• Symposium 6B: Old problems, new solutions in Haematology
  • Molecular diagnosis of haemoglobin disorders
  • Non-myeloablative cord blood transplantation in adults
  • Cellular molecular imaging - the way forward
• Symposium 6C: Molecular diagnosis of viral disorders
  • Molecular diagnosis of viral disorders: HIV
  • Hepatitis C
  • Review on Hepatitis B and chronic Hepatitis B
• Symposium 6D: Current issues in fine needle aspiration cytology
  • FNA of liver: diagnosis of hepatocellular carcinoma
  • FNA of lymph node: Is it good enough for diagnosis of lymphomas?
  • FNA of the breast: Do we still need core needle biopsies for diagnosis        of breast cancers?
• Symposium 6E: Education and research for pathologists
  • Appraising the literature: can we believe what we read?
  • Molecular diagnosis: strengths and pitfalls
  • Research for surgical pathologists
• Lunch Symposium 1: Bricks, Tools, Chips, Brains for the        modernisation of Laboratory Medicine in Italy and Europe
  • Downsizing and modernization of Laboratory Medicine in Italy and        SIMeL
  • Information technology, LIS and HIS: A never ending story
  • An electronic thesaurus of EBLM diagnostic tests
  • Pathology education and research in Germany
• Lunch Symposium 2: Strategic planning and budgeting for pathology        laboratories
  • Strategic planning for a pathology laboratory
  • Budgets and the budgeting process: What the pathologists need to        know
  • Assessing productivity and efficiency in the clinical laboratory:        Understanding the basic tools
  • Resolving conflict in the pathology laboratory
• Lunch Symposium 3: Update in cardiac pathology
  • Pathology of the cardiomyopathies
  • The autopsy approach to sudden cardiac death
  • An approach to interpretation of endomyocardial biopsies
• Poster abstracts
  • PDF version (1,544kb)
• Index of speakers and presenters
  • PDF version (211kb)